Financhill
Back

Spyre Therapeutics Vs. Matthews International Industry Stock Comparison

Sell
42

SYRE
Spyre Therapeutics

Last Price:
$18.91
Seasonality Move:
-17.1%
Sell
26

MATW
Matthews International

Last Price:
$22.83
Seasonality Move:
3.26%
Sell
42
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $18.88. The Score for SYRE is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Matthews International (MATW) is a Sell

Is Matthews International a Buy, Sell or Hold?

  • The current Matthews International [MATW] share price is $22.79. The Score for MATW is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • MATW is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $18.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight selling pressure.

MATW Stock Price Chart

What is Matthews International's stock price today?

  • The Matthews International share price today is $22.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MATW is experiencing slight buying pressure.

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.02 Sell
Relative Strength Index (14 RSI): 41.16 Sell
Chaikin Money Flow: -31760 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.23 - 23.11) Sell
Bollinger Bands (100): (20.63 - 31.37) Sell

MATW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.08 Sell
Relative Strength Index (14 RSI): 35.33 Sell
Chaikin Money Flow: 86515 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.58 - 26.6) Sell
Bollinger Bands (100): (23.58 - 29.56) Sell

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.09 Sell
20-day SMA: 20.63 Sell
50-day SMA: 21.84 Sell
200-day SMA: 27.37 Sell
8-day EMA: 19.3 Sell
20-day EMA: 20.26 Sell
50-day EMA: 22.07 Sell
200-day EMA: 25.7 Sell

MATW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.76 Sell
20-day SMA: 24.47 Sell
50-day SMA: 27.08 Sell
200-day SMA: 26 Sell
8-day EMA: 23.73 Sell
20-day EMA: 24.72 Sell
50-day EMA: 26.09 Sell
200-day EMA: 27.08 Sell

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.16 per share, an increase this year of $0.82 per share, and a decrease next year of $0.26 per share.

Matthews International Earnings Growth & MATW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and an increase next year of $0.29 per share.

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Matthews International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):